Navigation Links
Update on the SEAS Study
Date:7/21/2008

LONDON, July 21 /PRNewswire/ -- Professor Terje Pedersen (Ulleval University Hospital, Oslo, Norway), lead investigator for the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study, will provide an update on the study on Monday the 21st July.

Also present in London will be Sir Richard Peto (Professor of Medical Statistics and Epidemiology and Co-director of the Clinical Trials Service Unit, University of Oxford) Professor Rory Collins (BHF Professor of Medicine and Epidemiology at the University of Oxford and Co-director of the Clinical Trials Service Unit) and Professor Ingar Holme, PhD, (Professor of Biostatistics, University of Oslo and Ulleval University Hospital, Oslo, Norway), SEAS steering committee statistician.

The London panel will be joined by Professor Eugene Braunwald (Professor of Medicine at Harvard Medical School) who will participate via Web link from Boston and Professor Robert M Califf (Professor of Medicine, Head of Duke Clinical Research, Duke University) available via phone link.
You are invited to join us at:

The Hilton London Metropole Hotel,

King Suite (3rd Floor, West Wing),

225 Edgware Road, London W2 1JU

When: 21st July at 5.30pm for a 6pm start, BST

OR

The press conference will be Webcast live, and archived, available at:

http://clients.mediaondemand.net/pedersen/live.asx

http://clients.mediaondemand.net/pedersen/archive.asx Additionally the press conference can be accessed via satellite and full coordinates for USA and Europe will be issued by 1pm BST.

There will be a Q&A session after the press announcement. The Q&A session is only available for members of the media.


'/>"/>
SOURCE ;
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
2. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
3. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
4. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
5. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
6. Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
7. GSK Update on FDA Review of Promacta(R) (Eltrombopag)
8. XTENT Announces European Regulatory Update
9. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
10. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
11. Genmab Announces Updates on Phase III Cancer Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc ... reached agreements to resolve virtually all known U.S. mesh ... discussions to resolve the known remaining U.S. claims at ... payments beginning in the fourth quarter of 2017 and ... of its second quarter 2017 results, the Company intends ...
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
(Date:8/2/2017)... Aug. 2, 2017 Fenita J. ... as a Pinnacle Lifetime Professional in the Field ... Manager at Turing Pharmaceuticals, AG. Her skills and ... relationship building.                ... 25 years of experience as a highly successful ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... “Emotions are sacred, valid, honored, encouraged. This ... positive education company Generation Mindful. To help change the mindset of parents and educators ... skills, she created the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... Alcovit, a ... to ramp up its marketing efforts with its product now available through Jet.com. ... to the public. The effervescent powdered drink is designed to quickly detox the body ...
(Date:8/18/2017)... ... ... “Our Mountains to Climb: A Journey of Love and Faith Through Trials”: ... faith they shared to overcome struggles in life. “Our Mountains to Climb: A Journey ... Corcoran, a retired teacher and happily married since 1999; the author’s personal experiences drive ...
(Date:8/18/2017)... ... ... “Beyond Our Imaginations: The Infinite God”: shows the importance of God in living ... of published author, Mark Lawrence, born in Michigan, the author has lived in various ... greater man of God is that I have to be more mindful of feminine ...
(Date:8/18/2017)... ... ... Mandate for Kingdom Builders”: a call to walk as citizens of the Kingdom and ... published author, John F. McGeorge, Jr. Dr. John F. McGeorge Jr., B.A., J.D., ... three decades training pastors and Christian leaders. He also met his wife, Valerija, ...
Breaking Medicine News(10 mins):